SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-026626
Filing Date
2023-08-03
Accepted
2023-08-03 16:30:47
Documents
14
Period of Report
2023-08-02
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 41752
2 ex99-1.htm EX-99.1 80391
3 ex99-1_002.jpg GRAPHIC 3413
  Complete submission text file 0001493152-23-026626.txt   316700

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE mymd-20230802.xsd EX-101.SCH 3003
5 XBRL LABEL FILE mymd-20230802_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE mymd-20230802_pre.xml EX-101.PRE 22351
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3444
Mailing Address 855 N. WOLFE STREET SUITE 623 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 623 BALTIMORE MD 21205 856-848-8698
MyMD Pharmaceuticals, Inc. (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36268 | Film No.: 231140588
SIC: 2835 In Vitro & In Vivo Diagnostic Substances